Form 990 for tax year 2024
Filed by AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION.
Totals
- Total revenue
- $3,585,475
- Total expenses
- $3,245,282
- Contributions and grants received
- $1,714,721
- Grants paid
- $730,281
- Program service revenue
- $1,199,097
- Investment income
- $671,657
- Other revenue
- $0
- Total assets, end of year
- $14,275,101
- Total liabilities, end of year
- $673,342
- Net assets or fund balances, end of year
- $13,601,759
- Program services expenses (Part IX)
- $2,103,974
- Management and general expenses
- $364,982
- Fundraising expenses
- $776,326
- Program service expenses (Part III)
- $2,103,974
Program services were 64.8% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1d · Related organizations
$367,250
-
1f · All other contributions, gifts and grants
$1,347,471
-
1g · Noncash contributions included above
$10,301
-
2a · Program service revenue: PHARMACY LEADERSHIP ACADEMY
total $646,180 · related or exempt $646,180
-
2b · Program service revenue: CORPORATE PARTNER PROGRAM
total $517,917 · related or exempt $517,917
-
2c · Program service revenue: SPONSORSHIPS
total $35,000 · excluded $35,000
-
3 · Investment income
total $527,852 · excluded $527,852
-
7a · Gross sales of assets other than inventory
securities $1,003,374
-
7b · Less cost or other basis and sales expenses
securities $859,569
-
7c · Gain or loss
securities $143,805
-
7d · Net gain or loss
total $143,805 · excluded $143,805
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $677,495 · program services $677,495
-
2 · Grants to domestic individuals
total $52,786 · program services $52,786
-
5 · Compensation of officers, directors and key employees
total $1,121,931 · program services $575,422 · management and general $153,058 · fundraising $393,451
-
7 · Other salaries and wages
total $518,295 · program services $265,826 · management and general $70,708 · fundraising $181,761
-
8 · Pension plan contributions
total $33,625 · program services $17,246 · management and general $4,587 · fundraising $11,792
-
9 · Other employee benefits
total $12,051 · program services $6,181 · management and general $1,644 · fundraising $4,226
-
10 · Payroll taxes
total $101,600 · program services $52,109 · management and general $13,861 · fundraising $35,630
-
11c · Fees: accounting
total $13,750 · management and general $13,750
-
11f · Fees: investment management
total $5,740 · management and general $5,740
-
11g · Fees: other
total $421,685 · program services $351,763 · management and general $407 · fundraising $69,515
-
13 · Office expenses
total $59,399 · program services $45,429 · management and general $3,550 · fundraising $10,420
-
17 · Travel
total $156,186 · program services $26,740 · management and general $63,059 · fundraising $66,387
-
22 · Depreciation, depletion and amortization
total $29,977 · program services $29,977
-
24a · Other expenses: BAD DEBT EXPENSE
total $22,500 · management and general $22,500
-
24b · Other expenses: CREDIT CARD FEES
total $15,262 · management and general $12,118 · fundraising $3,144
-
24c · Other expenses: HONORARIA
total $3,000 · program services $3,000
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $38,721 · end of year $126,440
-
3 · Pledges and grants receivable
beginning of year $761,302 · end of year $670,868
-
4 · Accounts receivable
beginning of year $101,119 · end of year $48,791
-
9 · Prepaid expenses and deferred charges
beginning of year $50,671 · end of year $31,624
-
10a · Land, buildings and equipment: cost or other basis
$299,790
-
10b · Land, buildings and equipment: accumulated depreciation
$289,396
-
10c · Land, buildings and equipment, net
beginning of year $40,371 · end of year $10,394
-
11 · Investments: publicly traded securities
beginning of year $12,511,946 · end of year $13,277,956
-
12 · Investments: other securities
beginning of year $63,017 · end of year $557
-
15 · Other assets
beginning of year $5,423 · end of year $108,471
-
17 · Accounts payable and accrued expenses
beginning of year $135,070 · end of year $209,059
-
19 · Deferred revenue
beginning of year $466,133 · end of year $464,283
-
25 · Other liabilities
beginning of year $122,989 · end of year $0
-
27 · Net assets without donor restrictions
beginning of year $3,940,565 · end of year $4,457,187
-
28 · Net assets with donor restrictions
beginning of year $8,907,813 · end of year $9,144,572
Mission and programs · 2024
Mission
OUR MISSION: SUPPORT ASHP BY ADVANCING THE PROFESSIONAL PRACTICE OF PHARMACISTS AND THE PHARMACY WORKFORCE BY FUNDING RESEARCH AND EDUCATION THAT IMPROVES HEALTH OUTCOMES THROUGH OPTIMAL, SAFE, AND EFFECTIVE MEDICATION USE.
Activities or mission (Part I)
THE MISSION OF THE ASHP FOUNDATION IS TO SUPPORT ASHP BY ADVANCING (CONTINUED ON SCHEDULE O)THE PROFESSIONAL PRACTICE OF PHARMACISTS AND THE PHARMACY WORKFORCE BY FUNDING RESEARCH AND EDUCATION THAT IMPROVES HEALTH OUTCOMES THROUGH OPTIMAL, SAFE, AND EFFECTIVE MEDICATION USE.
-
EXCELLENCE IN PHARMACY PRACTICE AND LEADERSHIP DEVELOPMENT: RECOGNIZE AND PROMOTE EFFORTS THAT FOSTER EXCELLENCE AND GROWTH OF HEALTH-SYSTEM PHARMACY. ASHP STUDENT LEADERSHIP AWARD: THIS PROGRAM, FUNDED THROUGH THE DAVID A. ZILZ FUND, IS ADMINISTERED BY THE ASHP PHARMACY STUDENT FORUM IN COLLABORATION WITH THE ASHP FOUNDATION. TWELVE STUDENTS WHO DEMONSTRATED HIGH ACADEMIC ACHIEVEMENT, EXCEPTIONAL INTEREST IN HEALTH-SYSTEM PHARMACY PRACTICE, AND OUTSTANDING LEADERSHIP SKILLS WERE RECOGNIZED. THE AWARDEES RECEIVED A PLAQUE, A $2,000 AWARD AND AN ASHP DRUG INFORMATION LIBRARY. EACH AWARDEE SUBMITTED A PLAN TO RAISE STUDENT AWARENESS OF THE ASHP PRACTICE ADVANCEMENT INITIATIVE. AWARDEES WILL BE SURVEYED TO COLLECT INFORMATION ON THE IMPLEMENTATION AND OUTCOMES OF THEIR PLAN.PHARMACY RESIDENCY EXCELLENCE AWARDS PROGRAM: SAMSON MEDICAL TECHNOLOGIES AND MEDI-DOSE SUPPORTED THE 2024 PHARMACY RESIDENCY EXCELLENCE AWARDS PROGRAM. THIS UNIQUE AWARD RECOGNIZES EXCELLENCE AND LEADERSHIP IN THE TRAINING AND MENTORING OF PHARMACY RESIDENTS. THE PHARMACY RESIDENCY EXCELLENCE AWARDS PROGRAM RECOGNIZES A PRECEPTOR, NEW PRECEPTOR AND PROGRAM. THE OBJECTIVES OF THIS PROGRAM ARE TO: 1) RECOGNIZE THE ACHIEVEMENTS OF RESIDENCY PROGRAMS AND PHARMACISTS WHO HAVE DEMONSTRATED EXCELLENCE AND LEADERSHIP IN THE TRAINING OF PHARMACY RESIDENTS AND 2) WIDELY DISSEMINATE THE RESULTS OF THESE ACCOMPLISHMENTS TO FOSTER INNOVATIONS IN PHARMACY RESIDENT TRAINING. AWARDEES RECEIVE A PLAQUE AND PARTICIPATE IN SHORT INTERVIEWS AND ARE RECOGNIZED THROUGH VARIOUS ELECTRONIC PLATFORMS AND AT THE ASHP MIDYEAR CLINICAL MEETING AND EXHIBITION (ASHP MIDYEAR). EACH AWARDEE WILL ALSO PRESENT AN EDUCATIONAL WEBINAR ON RESIDENT PROFESSIONAL DEVELOPMENT TOPICS. THE WEBINARS ARE RECORDED AND MADE AVAILABLE FOR ON-DEMAND ACCESS. LITERATURE AWARDS PROGRAM: THE ASHP FOUNDATION LITERATURE AWARDS PROGRAM RECOGNIZES IMPORTANT CONTRIBUTIONS TO BIOMEDICAL LITERATURE BY PHARMACISTS. THIS PROGRAM, ADMINISTERED BY THE ASHP FOUNDATION SINCE 1971, RECOGNIZES TO STIMULATE INNOVATION AND FOSTERS IMPROVEMENT IN THE QUALITY OF THE EVIDENCE. AWARDEES WERE RECOGNIZED IN FIVE (5) DIFFERENT CATEGORIES IN 2024. AWARDEES RECEIVE AN HONORARIUM, PLAQUE, PARTICIPATE IN SHORT INTERVIEWS AND PODCASTS, AND ARE RECOGNIZED THROUGH VARIOUS ELECTRONIC PLATFORMS AND AT THE ASHP MIDYEAR MEETING. MIDYEAR TRAVEL AWARD: THE MIDYEAR TRAVEL AWARD, ORIGINALLY CREATED AS A COLLABORATION BETWEEN THE ASHP FOUNDATION AND #PHARMGRADWISHLIST, AWARDED 32 PHARMD CANDIDATES WITH A $500 TRAVEL STIPEND, REGISTRATION TO THE ASHP MIDYEAR MEETING, AND A ONE-YEAR ASHP MEMBERSHIP. THERE WERE 260 APPLICATIONS RECEIVED FOR THE AWARD IN FY25. THE PROGRAM WAS PARTIALLY FUNDED VIA $25,000 DONATIONS EACH FROM MARVIN SAMSON AND APEXUS, ALONG WITH INDIVIDUAL DONATIONS. ASHP FOUNDATION PHARMACY STUDENT SCHOLARSHIP: IN FY25, THE ASHP FOUNDATION ENGAGED WITH SELECTED RECIPIENTS OF THE PHARMACY STUDENT SCHOLARSHIP. THE SCHOLARSHIP WAS AWARDED IN SPRING 2025 (FY24) THROUGH FOUR US-ACCREDITED HISTORICALLY BLACK COLLEGES AND UNIVERSITIES (HBCUS) SCHOOLS OF PHARMACY FOR THE 2024-2025 ACADEMIC YEAR. NO SCHOLARSHIPS WERE AWARDED THROUGH THIS PROGRAM IN FY25. PHARMACIST NUTRITION SUPPORT PATIENT-CARE IMPACT PROGRAM: SUPPORTED BY AN EDUCATIONAL GRANT FROM BAXTER AND OFFERED IN COLLABORATION WITH ASHP'S SECTION ON CLINICAL SPECIALISTS AND SCIENTISTS, THE PHARMACIST NUTRITION SUPPORT PATIENT-CARE IMPACT PROGRAM DISTANCE PROGRAM IS DESIGNED TO DEVELOP LEADERS WITH KNOWLEDGE AND SKILLS TO OPTIMIZE SAFE AND EFFECTIVE NUTRITIONAL SUPPORT NEEDS OF PATIENTS. A COHORT OF EIGHT PHARMACY RESIDENTS IN PGY2 PROGRAMS WERE SELECTED TO COMPLETE THE PROGRAM WITH THEIR PRECEPTOR. THE PREVIOUS COHORT COMPLETED THE EXPERIENTIAL PORTION OF THE PROGRAM THROUGHOUT FY25. THE APPLICATION FOR A NEW CYCLE OPENED IN FY25, WITH THE COHORT SELECTED IN FY26. MEDICATION SAFETY SCHOLARS: ASHP FOUNDATION IN PARTNERSHIP WITH EMILY JERRY FOUNDATION AND THE ASHP STUDENT FORUM SELECTED PARTICIPANTS FOR THE MEDICATION SAFETY SCHOLARS PROGRAM. THE COHORT PARTICIPATED IN A DISTANCE IMPACT PROGRAM STRUCTURED TO SUPPORT FIVE P2 AND P3 DOCTOR OF PHARMACY STUDENTS, PAIRED WITH ONE GROUP COACH, TO ENHANCE THEIR KNOWLEDGE AND SKILLS IN MEDICATION SAFETY. THE COHORT WILL HAVE A NETWORKING DINNER AND FINALIZE THEIR PROJECT IN FY26. PHARMACY RESIDENCY EXPANSION GRANT: IN FY25, SUPPORTED BY AN EDUCATIONAL DONATION FROM MERCK & CO., INC., RAHWAY, NJ, USA, THE ASHP FOUNDATION AWARDED A TOTAL OF $75,000 DOLLARS IN GRANTS TO THREE (3) PGY-1 AND PGY-2 PHARMACY RESIDENCY PROGRAMS TO INCREASE THE NUMBER OF AVAILABLE TRAINING POSITIONS. PHARMACY STUDENT CLINICAL SKILLS COMPETITION: GABRIELLA MIGNOSA AND EMMA VAN REYSEN FROM THE UNIVERSITY OF RHODE ISLAND COLLEGE OF PHARMACY COMPETED FOR THE 2024 ASHP NATIONAL CLINICAL SKILLS COMPETITION, AND WON THE COMPETITION IN DECEMBER 2024, DURING THE ASHP MIDYEAR CLINICAL MEETING IN NEW ORLEANS, LA. THE FOUNDATION HAS SPONSORED THE PHARMACY STUDENT CLINICAL SKILLS COMPETITION (CSC) AT THE ASHP MIDYEAR CLINICAL MEETING FOR 19 YEARS. TEAMS WHO WON PRELIMINARY COMPETITIONS AT THEIR LOCAL PHARMACY SCHOOL PARTICIPATED IN THE COMPETITION. DURING THE CSC, STUDENTS DEMONSTRATE THEIR SKILLS BY ASSESSING PATIENT INFORMATION AND CURRENT THERAPY, IDENTIFYING AND PRIORITIZING DRUG THERAPY PROBLEMS, IDENTIFYING TREATMENT GOALS, AND RECOMMENDING A PHARMACIST CARE PLAN.EXCELLENCE IN RESIDENCY: FUNDED THROUGH THE DANIEL M. ASHBY FUND FOR EXCELLENCE IN PHARMACY RESIDENCY TRAINING, THE FOUNDATION CONTRACTED WITH UNIVERSITY OF GEORGIA (UGA) AND ASHP'S ACCREDITATION SERVICES DIVISION ON A GRANT TO UGA AND SUBSEQUENT RESEARCH PROJECT TO STUDY RESIDENTS' PROGRAM EXPERIENCES AND COMPLETION. PHARMACY LEADERSHIP ACADEMY (PLA): THE PLA, SUPPORTED IN PART BY A DONATION FROM APEXUS, IS AN ONLINE EDUCATION PROGRAM DESIGNED TO PROVIDE COMPREHENSIVE LEADERSHIP EDUCATION TO PHARMACISTS AND PHARMACY TECHNICIANS. THE PLA CLASS IN FY25 CONSISTED OF 104 PARTICIPANTS, WHO ALSO REMITTED TUITION AND WERE ENROLLED IN THE PROGRAM FROM JULY 2024 TO JUNE 2025. THE NUMBER OF GRADUATES FROM THIS CLASS BRINGS THE TOTAL NUMBER OF PLA GRADUATES ALMOST 1,400.WILLIAM A. ZELLMER LEADERSHIP LECTURE: WHERE PRACTICE MEETS POLICY:THIS ANNUAL LUNCHEON-LECTURE EVENT, HOSTED BY ASHP IN PARTNERSHIP WITH THE ASHP FOUNDATION, IS DESIGNED TO HONOR THE DISTINGUISHED 40-YEAR ASHP CAREER OF WILLIAM A. ZELLMER AND IS SUPPORTED BY DONORS TO THE ASHP FOUNDATION'S WILLIAM ZELLMER FUND. COL. WILLIAM MICHAEL HEATH, MBA PRESENTED THE LECTURE ON SEPTEMBER 17, 2024, DURING ASHP'S ANNUAL POLICY WEEK ACTIVITIES. JOSEPH A. ODDIS ETHICS COLLOQUIUM:THE JOSEPH A. ODDIS ETHICS COLLOQUIUM FOCUSED ON THE TOPICS: ETHICAL DIMENSION OF ARTIFICIAL INTELLIGENCE (AI) IN PHARMACY. THE SESSION WAS PLANNED AND LED BY THE PROGRAM CHAIR IN JUNE DURING THE 2024 ASHP PHARMACY FUTURES MEETING IN PORTLAND, OR.STRATEGIC EXECUTION PROJECT:SUPPORTED BY A DONATION FROM OMNICELL, INC. AND FUNDS FROM THE DAVID A. ZILZ LEADERS FOR THE FUTURE FUND AND MARIANNE F. IVEY FUND FOR PHARMACY LEADERSHIP DEVELOPMENT, A SURVEY PROJECT WAS LAUNCHED TO EXPLORE THE CURRENT STATE OF STRATEGIC PLANNING AND EXECUTION. A GOAL OF THE PROJECT IS TO PREPARE TOMORROW'S GENERATION OF PHARMACY LEADERS, BY UNDERSTANDING HOW THE LEADERS OF TODAY OPERATE THROUGH A SURVEY AND ANALYSIS OF THE RESULTS. HEALTH SYSTEM PHARMACY LEADERS WERE RECRUITED TO ADVISE ON THE DEVELOPMENT OF THE SURVEY AND ANALYSIS OF THE RESULTS. A MANUSCRIPT OF THE SURVEY RESULTS WAS SUBMITTED TO AJHP IN OCTOBER 2025. PLANNED FOR SPRING 2026 IS A RESULTS OVERVIEW INFOGRAPHIC AND A VIRTUAL NETWORKING SESSION TO ENGAGE LEADERS IN THE RESULTS AND PLANNING FUTURE ACTIVITIES.ASHP NATIONAL PUBLIC AWARENESS CAMPAIGN: THIS GRANT TO ASHP WAS PROVIDED TO SUPPORT THE DEVELOPMENT AND IMPLEMENTATION OF THE ASHP NATIONAL PUBLIC AWARENESS CAMPAIGN. THE GOAL OF THE PROJECT IS TO HAVE A COMPREHENSIVE NATIONAL AWARENESS CAMPAIGN TO BRING VISIBILITY AND RECOGNITION TO THE CRITICAL AND DIVERSE ROLES OF PHARMACISTS AND PHARMACY TECHNICIANS IN HOSPITALS AND HEALTH SYSTEMS.VISITING LEADERS PROGRAM (VLP): THE VISITING LEADERS PROGRAM, WITH SUPPORT FROM THE SARA J. WHITE LEADERSHIP FUND AND DAVID A. ZILZ LEADERS FOR THE FUTURE FUND, HAD ANOTHER SUCCESSFUL YEAR. NINE LEADERS WERE INVOLVED IN 16 RESIDENCY VISITS TO DISCUSS EMERGING LEADERSHIP TOPICS WITH PHARMACY RESIDENTS AND PRECEPTORS. SPECIALTY PHARMACY SURVEY:ASHP FOUNDATION PROVIDED THE REMAINING FUNDING OF $10,000 GRANTS TO ASHP FOR THE SPECIALTY PHARMACY SURVEY. THE INITIAL FUNDING WAS GRANTED IN FY24.
Expenses $1,268,696 · Grants $432,392 · Revenue $1,164,097
-
Withheld by Nonprofiteer: this text may name a private individual.
Expenses $835,278 · Grants $297,889
-
THE ASHP FOUNDATION CORPORATE PARTNERS PROGRAM IS A STRATEGIC PARTNERSHIP BETWEEN THE ASHP FOUNDATION, ASHP, AND CORPORATIONS WHICH PROMOTES MEDICATION SAFETY AND IMPROVEMENTS IN PATIENT CARE. THE PROGRAM OFFERS A ROBUST MENU OF SPONSORSHIP LEVELS AND BENEFITS FOR COMPANIES, FOCUSED ON COLLABORATION, RECOGNITION, AND INFORMATIONAL OPPORTUNITIES. THERE ARE FOUR SPONSORSHIP LEVELS AND A-LA-CARTE OPPORTUNITIES TO BETTER MEET BUSINESS OBJECTIVES. CORPORATE PARTNERS PROGRAM SPONSORSHIP IS ON AN ANNUAL BASIS. WITH THE GENEROUS SUPPORT OF CORPORATE PARTNERS, THE ASHP FOUNDATION INVESTS IN RESEARCH, AWARDS, EDUCATION, AND LEADERSHIP DEVELOPMENT THAT ADVANCES THE PHARMACY PROFESSION AND ENSURES THE SAFE, EFFECTIVE, AND OPTIMAL USE OF MEDICATIONS.
As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here. A text marked withheld matched a screen for wording that may name a private individual, such as an honorific or "in memory of". Most of what it withholds names no one; it is withheld so that what does is never shown.
Listed in Part VII
-
Kelly McCormick-SullivanKELLY MCCORMICK-SULLIVAN
SECRETARY AND CEO
- Total calculated
- $207,073
- From this org
- $185,739
- From related orgs
- $0
- Other
- $21,334
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $185,118
- Bonus
- $0
- Other
- $621
- Deferred
- $542
- Nontaxable benefits
- $20,792
- Filer's total
- $207,073
-
Kelly M SmithKELLY M SMITH
CHAIR
- Total calculated
- $0
- Hours/week
- 1
-
Ken PerezKEN PEREZ
VICE CHAIR
- Total calculated
- $0
- Hours/week
- 1
-
Paul W AbramowitzPAUL W ABRAMOWITZ
PRESIDENT
- Total calculated
- $1,231,032
- From this org
- $0
- From related orgs
- $1,165,359
- Other
- $65,673
- Hours/week
- 2 + 38 related
Schedule J breakdown matched by us
- Base
- $0 + $987,799 related
- Bonus
- $0 + $147,597 related
- Other
- $0 + $29,963 related
- Deferred
- $0 + $33,600 related
- Nontaxable benefits
- $0 + $32,073 related
- Filer's total
- $0 + $1,231,032 related
-
Christene JolowskyCHRISTENE JOLOWSKY
TREASURER
- Total calculated
- $0
- Hours/week
- 1 + 4 related
-
Roger AndersonROGER ANDERSON
DIRECTOR AT LARGE
- Total calculated
- $0
- Hours/week
- 1
-
Chris HatwigCHRIS HATWIG
DIRECTOR AT LARGE
- Total calculated
- $0
- Hours/week
- 1
-
Wendy HortonWENDY HORTON
DIRECTOR AT LARGE
- Total calculated
- $800
- From this org
- $0
- From related orgs
- $800
- Other
- $0
- Hours/week
- 1
-
Ellen MenardELLEN MENARD
DIRECTOR AT LARGE
- Total calculated
- $0
- Hours/week
- 1
-
Thomas J RiceTHOMAS J RICE
DIRECTOR AT LARGE
- Total calculated
- $0
- Hours/week
- 1
-
Scott M SamsonSCOTT M SAMSON
DIRECTOR AT LARGE
- Total calculated
- $0
- Hours/week
- 1
-
Lindsey ThomasLINDSEY THOMAS
DIRECTOR AT LARGE
- Total calculated
- $0
- Hours/week
- 1
-
Jon ZwinskiJON ZWINSKI
DIRECTOR AT LARGE
- Total calculated
- $0
- Hours/week
- 1
-
Nishaminy KasbekarNISHAMINY KASBEKAR
IMMEDIATE PAST PRESIDENT OF ASHP
- Total calculated
- $10,000
- From this org
- $0
- From related orgs
- $10,000
- Other
- $0
- Hours/week
- 1 + 2 related
-
Leigh Briscoe-DwyerLEIGH BRISCOE-DWYER
PRESIDENT OF ASHP
- Total calculated
- $10,000
- From this org
- $0
- From related orgs
- $10,000
- Other
- $0
- Hours/week
- 1 + 5 related
-
Barbara NussbaumBARBARA NUSSBAUM
VP, RESEARCH AND EDUCATION
- Total calculated
- $263,461
- From this org
- $206,516
- From related orgs
- $0
- Other
- $56,945
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $200,737
- Bonus
- $3,809
- Other
- $1,970
- Deferred
- $21,214
- Nontaxable benefits
- $35,731
- Filer's total
- $263,461
-
Martha CrewsMARTHA CREWS
VP, DEVELOPMENT
- Total calculated
- $198,768
- From this org
- $148,601
- From related orgs
- $0
- Other
- $50,167
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $144,492
- Bonus
- $2,755
- Other
- $1,354
- Deferred
- $15,346
- Nontaxable benefits
- $34,821
- Filer's total
- $198,768
-
Stephanie BrownSTEPHANIE BROWN
SENIOR DIRECTOR, OPERATIONS
- Total calculated
- $163,412
- From this org
- $134,570
- From related orgs
- $0
- Other
- $28,842
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $131,676
- Bonus
- $2,380
- Other
- $514
- Deferred
- $13,258
- Nontaxable benefits
- $15,584
- Filer's total
- $163,412
-
Steven A RubloffSTEVEN A RUBLOFF
SECRETARY AND CEO
- Total calculated
- $289,219
- From this org
- $242,866
- From related orgs
- $0
- Other
- $46,353
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $178,795
- Bonus
- $0
- Other
- $64,071
- Deferred
- $28,567
- Nontaxable benefits
- $17,786
- Filer's total
- $289,219
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
- 3 · Compensation committee
- 3 · Form 990 of other organizations
- 3 · Written employment contract
- 3 · Compensation survey or study
- 3 · Approval by the board or compensation committee
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 7 · Other non-fixed payments
Answered no
- 4a · Severance or change-of-control payment
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 8 · Paid under the initial-contract exception
The filer's explanations (Part III)
- PART I, LINE 6
- PAUL ABRAMOWITZ, PRESIDENT/ASHP CEO, AND STEVEN RUBLOFF, SECRETARY/ASHP REF CEO, RECEIVE A BONUS BASED ON THE ACHIEVEMENT OF SPECIFIC FINANCIAL AND NON-FINANCIAL OUTCOMES FOR THEIR RESPECTIVE ORGANIZATIONS.
- PART I, LINE 7
- ALL ASHP-REF EMPLOYEES ARE ELIGIBLE FOR AN ANNUAL PERFORMANCE INCENTIVE PROGRAM IN ACCORDANCE WITH POLICY, AT THE DISCRETION OF THE BOARD OF DIRECTORS, BASED ON MUTUALLY AGREED UPON PREDETERMINED OBJECTIVES.
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
-
ASHP STUDENT LEADERSHIP AWARD; DIVERSION PREVENTION ASSES TOOL; PHARMACY FORECAST REPORT; PHARMACY STUDENT CLINICAL SKILLS COMPETITION; ASHP NATIONAL PUBLIC AWARENESS CAMPAIGN; SPECIALTY PHARMACY SURVEY
-
VIRGINIA COMMONWEALTH UNIVERSITY
$74,820
COLLABORATIVE CARE GRANT FOR NURSES AND PHARMACISTS
-
COLLABORATIVE CARE GRANT FOR NURSES AND PHARMACISTS
-
$36,861
RADIO FREQUENCY IDENTIFICATION (RFID) INITIATIVE
-
UNIVERSITY OF NORTH CAROLINA HEALTHCARE SYSTEM
$30,000
OPTIMIZING TECHNOLOGY SOLUTIONS INNOVATION GRANT
-
STATE OF MARYLAND
$29,999
OPTIMIZING TECHNOLOGY SOLUTIONS INNOVATION GRANT
-
PHARMACY RESIDENCY EXPANSION GRANT
-
PHARMACY RESIDENCY EXPANSION GRANT
-
PHARMACY RESIDENCY EXPANSION GRANT
-
AMERICAN FOUNDATION FOR PHARMACEUTICAL EDUCATION (AFPE) PRE-DOCTORAL FELLOWSHIP
The 10 largest by cash amount. The API serves every itemized grant.
Related organizations on this return
Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.
-
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS (ASHP)
501(C)(6) · SEE PART VII FOR PRIMARY ACTIVITY · MD
-
THE PHARMACY TECHNICIAN SOCIETY INC
501(C)(6) · SEE PART VII FOR PRIMARY ACTIVITY · MD · controlled entity
Directly controlled by ASHP
Provenance
- Return type
- form_990
- Tax year
- 2024
- Filed
- 25 March 2026
- IRS schema version
- 2024v5.5
- Source object
- 202600899349300140
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.